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 The General Assembly,  
 Adopts the outcome document entitled “Our joint commitment to effectively 
addressing and countering the world drug problem” annexed to the present 
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Annex  
 
  Our joint commitment to effectively addressing and countering the 
world drug problem  
 
 
 We, heads of State and Government, ministers and representatives of Member 
States, assembled at United Nations Headquarters from 19 to 21 April 2016 for the 
thirtieth special session of the General Assembly, convened in accordance with 
Assembly resolution 67/193 of 20 December 2012, to review the progress in the 
implementation of the Political Declaration and Plan of Action on International 
Cooperation towards an Integrated and Balanced Strategy to Counter the World 
Drug Problem,1 including an assessment of the achievements and challenges in 
countering the world drug problem, within the framework of the three international 
drug control conventions and other relevant United Nations instruments;   
 We reaffirm our commitment to the goals and objectives of the three 
international drug control conventions, including concern with the health and 
welfare of humankind as well as the individual and public health -related, social and 
safety problems resulting from the abuse of narcotic drugs and psychotropic 
substances, in particular among children and young people, and drug -related crime, 
and we reaffirm our determination to prevent and treat the abuse of such substances 
and prevent and counter their illicit cultivation, production, manufacturi ng and 
trafficking;  
 We recognize that, while tangible progress has been achieved in some fields, 
the world drug problem continues to present challenges to the health, safety and 
well-being of all humanity, and we resolve to reinforce our national and 
international efforts and further increase international cooperation to face those 
challenges;  
 We reaffirm our determination to tackle the world drug problem and to 
actively promote a society free of drug abuse in order to help ensure that all people 
can live in health, dignity and peace, with security and prosperity and reaffirm our 
determination to address public health, safety and social problems resulting from 
drug abuse;  
 We note with concern that the availability of internationally controlled drugs 
for medical and scientific purposes, including for the relief of pain and suffering, 
remains low to non-existent in many countries of the world, and we highlight the 
need to enhance national efforts and international cooperation at all levels to 
address that situation by promoting measures to ensure their availability and 
accessibility for medical and scientific purposes, within the framework of national 
legal systems, while simultaneously preventing their diversion, abuse and trafficking,  
in order to fulfil the aims and objectives of the three international drug control 
conventions;  
 We recognize that the world drug problem remains a common and shared 
responsibility that should be addressed in a multilateral setting through effective and 
increased international cooperation and demands an integrated, multidisciplinary, 
__________________ 
 
1  See Official Records of the Economic and Social Council, 2009, Supplement No. 8  (E/2009/28), 
chap. I, sect. C.  
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mutually reinforcing, balanced, scientific evidence-based and comprehensive 
approach;  
 We reaffirm our unwavering commitment to ensuring that all aspects of 
demand reduction and related measures, supply reduction and related measures, and 
international cooperation are addressed in full conformity with the purposes and 
principles of the Charter of the United Nations, international law and the Universal 
Declaration of Human Rights,2 with full respect for the sovereignty and territorial 
integrity of States, the principle of non-intervention in the internal affairs of States, 
all human rights, fundamental freedoms, the inherent dignity of all individuals and 
the principles of equal rights and mutual respect among States;  
 We underscore that the Single Convention on Narcotic Drugs of 1961 as 
amended by the 1972 Protocol,3 the Convention on Psychotropic Substances of 
1971,4 the United Nations Convention against Illicit Traffic in Narcotic Drugs and 
Psychotropic Substances of 19885 and other relevant international instruments 
constitute the cornerstone of the international drug control system;   
 We reaffirm our commitment to implementing effectively the provisions set 
out in the Political Declaration and Plan of Action on International Cooperation 
towards an Integrated and Balanced Strategy to Counter the World Drug Problem, 
mindful of the targets and goals set therein, as well as to addressing the general 
challenges and priorities for action identified in the Joint Ministerial Statement 
adopted at the high-level review in March 2014;6  
 We welcome the 2030 Agenda for Sustainable Development,7 and we note that 
efforts to achieve the Sustainable Development Goals and to effectively address the 
world drug problem are complementary and mutually reinforcing;   
 We recognize, as part of a comprehensive, integrated and balanced approach to 
addressing and countering the world drug problem, that appropriate emphasis 
should be placed on individuals, families, communities and society as a whole, with 
a view to promoting and protecting the health, safety and well -being of all humanity;  
 We recognize the importance of appropriately mainstreaming gender and age 
perspectives in drug-related policies and programmes;  
 We recognize that there are persistent, new and evolving challenges that 
should be addressed in conformity with the three international drug control 
conventions, which allow for sufficient flexibility for States parties to design and 
implement national drug policies according to their priorities and needs, consistent 
with the principle of common and shared responsibility and applicable international 
law;  
__________________ 
 
2  Resolution 217 A (III).  
 
3  United Nations, Treaty Series, vol. 976, No. 14152.  
 
4  Ibid., vol. 1019, No. 14956.  
 
5  Ibid., vol. 1582, No. 27627.  
 
6  Joint Ministerial Statement of the 2014 high-level review by the Commission on Narcotic Drugs 
of the implementation by Member States of the Political Declaration and Plan of Action on 
International Cooperation towards an Integrated and Balanced Strategy to Counter the World 
Drug Problem (Official Records of the Economic and Social Council, 2014, Supplement No. 8 
(E/2014/28), chap. I, sect. C).  
 
7  Resolution 70/1.  
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 We reaffirm the need to mobilize adequate resources to address and counter 
the world drug problem and call for enhancing assistance to developing countries, 
upon request, in effectively implementing the Political Declaration and Plan of 
Action and the operational recommendations contained in the present document;   
 We recognize that transit States continue to face multifaceted challenges, and 
reaffirm the continuing need for cooperation and support, including the provision of 
technical assistance, to, inter alia, enhance their capacities to effectively address and 
counter the world drug problem, in conformity with the 1988 Convention;  
 We reaffirm the principal role of the Commission on Narcotic Drugs as the 
policymaking body of the United Nations with prime responsibility for drug control 
matters, and our support and appreciation for the efforts of the United  Nations, in 
particular those of the United Nations Office on Drugs and Crime as the leading 
entity in the United Nations system for addressing and countering the world drug 
problem, and further reaffirm the treaty-mandated roles of the International 
Narcotics Control Board and the World Health Organization;   
 We recognize that successfully addressing and countering the world drug 
problem requires close cooperation and coordination among domestic authorities at 
all levels, particularly in the health, education, justice and law enforcement sectors, 
taking into account their respective areas of competence under national legislation;   
 We welcome continued efforts to enhance coherence within the United Nations 
system at all levels;  
 We recognize that civil society, as well as the scientific community and 
academia, plays an important role in addressing and countering the world drug 
problem, and note that affected populations and representatives of civil society 
entities, where appropriate, should be enabled to play a participatory role in the 
formulation, implementation, and the providing of relevant scientific evidence in 
support of, as appropriate, the evaluation of drug control policies and programmes, 
and we recognize the importance of cooperation with the private sector in this regard;  
 We express deep concern at the high price paid by society and by individuals 
and their families as a result of the world drug problem, and pay special tribute to 
those who have sacrificed their lives, in particular law enforcement and judicial 
personnel, and to the health-care and civil society personnel and volunteers who 
dedicate themselves to countering and addressing this phenomenon;   
 We reaffirm the need to strengthen cooperation between the United Nations 
Office on Drugs and Crime and other United Nations entities, within their respective 
mandates, in their efforts to support Member States in the implementation of 
international drug control treaties in accordance with applicable human rights 
obligations and to promote protection of and respect for human rights and the 
dignity of all individuals in the context of drug programmes, strategies and policies;   
 We reaffirm the need to address the key causes and consequences of the world 
drug problem, including those in the health, social, human rights, economic, justice, 
public security and law enforcement fields, in line with the principle of common 
and shared responsibility, and recognize the value of comprehensive and balanced 
policy interventions, including those in the field of promotion of sustainable and 
viable livelihoods;  
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 We reaffirm that targeted interventions that are based on the collection and 
analysis of data, including age- and gender-related data, can be particularly effective 
in meeting the specific needs of drug-affected populations and communities;  
 We reiterate our commitment to end by 2030 the epidemics of AIDS and 
tuberculosis, as well as combat viral hepatitis, other communicable diseases, inter 
alia, among people who use drugs, including people who injec t drugs.  
 
 
  Operational recommendations on demand reduction and related 
measures, including prevention and treatment, as well as other 
health-related issues 
 
 
1. We reiterate our commitment to promote the health, welfare and well -being of 
all individuals, families, communities and society as a whole, and facilitate healthy 
lifestyles through effective, comprehensive, scientific evidence -based demand 
reduction initiatives at all levels, covering, in accordance with national legislation 
and the three international drug control conventions, prevention, early intervention, 
treatment, care, recovery, rehabilitation and social reintegration measures, as well as 
initiatives and measures aimed at minimizing the adverse public health and social 
consequences of drug abuse, and we recommend the following measures:  
 
  Prevention of drug abuse  
 
 (a) Take effective and practical primary prevention measures that protect 
people, in particular children and youth, from drug use initiation by providing them 
with accurate information about the risks of drug abuse, by promoting skills and 
opportunities to choose healthy lifestyles and develop supportive parenting and 
healthy social environments and by ensuring equal access to education and 
vocational training;  
 (b) Also take effective and practical measures to prevent progression to 
severe drug use disorders through appropriately targeted early interventions for 
people at risk of such progression;  
 (c) Increase the availability, coverage and quality of scientific evidence -
based prevention measures and tools that target relevant age and risk groups in 
multiple settings, reaching youth in school as well as out of school, among others, 
through drug abuse prevention programmes and public awareness -raising 
campaigns, including by using the Internet, social media and other online platforms, 
develop and implement prevention curricula and early intervention programmes for 
use in the education system at all levels, as well as in vocational training, including 
in the workplace, and enhance the capacity of teachers and other relevant 
professionals to provide or recommend counselling, prevention and care services;   
 (d) Promote the well-being of society as a whole through the elaboration of 
effective scientific evidence-based prevention strategies centred on and tailored to 
the needs of individuals, families and communities as part of comprehensive and 
balanced national drug policies, on a non-discriminatory basis;  
 (e) Involve, as appropriate, policymakers, parliamentarians, educators, c ivil 
society, the scientific community, academia, target populations, individuals in 
recovery from substance use disorders and their peer groups, families and other 
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co-dependent people, as well as the private sector, in the development of prevention 
programmes aimed at raising public awareness of the dangers and risks associated 
with drug abuse, and involve, inter alia, parents, care services providers, teachers, 
peer groups, health professionals, religious communities, community leaders, social 
workers, sports associations, media professionals and entertainment industries, as 
appropriate, in their implementation;  
 (f) Consider enhancing cooperation between public health, education and 
law enforcement authorities when developing prevention initiatives;   
 (g) Develop and improve recreational facilities and provide access for 
children and youth to regular sports and cultural activities, with a view to promoting 
healthy lives and lifestyles, including through the recovery and improvement of 
public spaces, and promote the exchange of experiences and good practices in this 
field to further enhance effective preventive interventions;   
 (h) Promote and improve the systematic collection of information and 
gathering of evidence as well as the sharing, at the national and international levels, 
of reliable and comparable data on drug use and epidemiology, including on social, 
economic and other risk factors, and promote, as appropriate, through the 
Commission on Narcotic Drugs and the World Health Assembly, the use of 
internationally recognized standards, such as the International Standards on Drug 
Use Prevention, and the exchange of best practices, to formulate effective drug use 
prevention strategies and programmes in cooperation with the United Nations Office 
on Drugs and Crime, the World Health Organization and other relevant United 
Nations entities;  
 
  Treatment of drug use disorders, rehabilitation, recovery and social reintegration;  
prevention, treatment and care of HIV/AIDS, viral hepatitis and other blood-borne 
infectious diseases  
 
 (i) Recognize drug dependence as a complex, multifactorial health disorder 
characterized by a chronic and relapsing nature with social causes and consequences 
that can be prevented and treated through, inter alia, effective scientif ic evidence-
based drug treatment, care and rehabilitation programmes, including community -
based programmes, and strengthen capacity for aftercare for and the rehabilitation, 
recovery and social reintegration of individuals with substance use disorders, 
including, as appropriate, through assistance for effective reintegration into the 
labour market and other support services;  
 (j) Encourage the voluntary participation of individuals with drug use 
disorders in treatment programmes, with informed consent, where consistent with 
national legislation, and develop and implement outreach programmes and 
campaigns, involving drug users in long-term recovery, where appropriate, to 
prevent social marginalization and promote non-stigmatizing attitudes, as well as to 
encourage drug users to seek treatment and care, and take measures to facilitate 
access to treatment and expand capacity;  
 (k) Promote and strengthen regional and international cooperation in 
developing and implementing treatment-related initiatives, enhance technical 
assistance and capacity-building and ensure non-discriminatory access to a broad 
range of interventions, including psychosocial, behavioural and medication -assisted 
treatment, as appropriate and in accordance with national legislation, as well a s to 
 
A/S-30/L.1 
 
7/24 16-06128 
 
rehabilitation, social reintegration and recovery-support programmes, including 
access to such services in prisons and after imprisonment, giving special attention to 
the specific needs of women, children and youth in this regard;   
 (l) Develop and strengthen, as appropriate, the capacity of health, social and 
law enforcement and other criminal justice authorities to cooperate, within their 
mandates, in the implementation of comprehensive, integrated and balanced 
responses to drug abuse and drug use disorders, at all levels of government;  
 (m) Promote the inclusion in national drug policies, in accordance with 
national legislation and as appropriate, of elements for the prevention and treatment 
of drug overdose, in particular opioid overdose, including the use of opioid receptor 
antagonists such as naloxone to reduce drug-related mortality;  
 (n) Promote cooperation with and technical assistance to the States most 
affected by the transit of drugs in developing and implementing comprehensive and 
integrated policies to address, where appropriate, the impact of illicit drug 
trafficking on increasing drug use in such States, including by reinforcing national 
programmes aimed at prevention, early intervention, treatment, care, rehabilitation 
and social reintegration;  
 (o) Invite relevant national authorities to consider, in accordance with their 
national legislation and the three international drug control conventions, including 
in national prevention, treatment, care, recovery, rehabilitation and social 
reintegration measures and programmes, in the context of comprehensive and 
balanced drug demand reduction efforts, effective measures aimed at minimizing the 
adverse public health and social consequences of drug abuse, including appropriate 
medication-assisted therapy programmes, injecting equipment programmes, as well 
as antiretroviral therapy and other relevant interventions that prevent the 
transmission of HIV, viral hepatitis and other blood -borne diseases associated with 
drug use, as well as consider ensuring access to such interventions including in 
treatment and outreach services, prisons and other custodial settings, and promoting 
in that regard the use, as appropriate, of the WHO, UNODC and UNAIDS Technical 
Guide for Countries to Set Targets for Universal Access to HIV Prevention, 
Treatment and Care for Injecting Drug Users;8  
 (p) Promote and implement the standards on the treatment of drug use 
disorders developed by the United Nations Office on Drugs and Crime and the 
World Health Organization and other relevant international standards, as appropriate 
and in accordance with national legislation and the international drug control 
conventions, and provide guidance, assistance and training to health professionals on 
their appropriate use, and consider developing standards and accreditation for services 
at the domestic level to ensure qualified and scientific evidence -based responses;  
 (q) Intensify, as appropriate, the meaningful participation of and support and 
training for civil society organizations and entities involved in drug-related health 
and social treatment services, in accordance with national legislation and in the 
framework of integrated and coordinated national drug policies, and encourage 
efforts by civil society and the private sector to develop support networks for 
prevention and treatment, care, recovery, rehabilitation and social reintegration in a 
balanced and inclusive manner;  
__________________ 
 
8  World Health Organization (Geneva, 2009).  
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 (r) Encourage the United Nations Office on Drugs and Crime and the 
International Narcotics Control Board to strengthen cooperation with the World 
Health Organization and other competent United Nations entities, within their 
respective mandates, as part of a comprehensive, integrated and balanced approach 
to strengthening health and social welfare measures in addressing the world drug 
problem, including through effective prevention, early intervention, treatment, care, 
recovery, rehabilitation and social reintegration, in cooperation, as appropriate, with 
civil society and the scientific community, and to keep the Commission on Narcotic 
Drugs appropriately updated.  
 
 
  Operational recommendations on ensuring the availability of and 
access to controlled substances exclusively for medical and 
scientific purposes, while preventing their diversion  
 
 
2. We reiterate our strong commitment to improving access to controlled 
substances for medical and scientific purposes by appropriately addressing existing 
barriers in this regard, including those related to legislation, regulatory systems, 
health-care systems, affordability, the training of health-care professionals, 
education, awareness-raising, estimates, assessment and reporting, benchmarks for 
consumption of substances under control, and international cooperation and 
coordination, while concurrently preventing their diversion, abuse and trafficking, 
and we recommend the following measures:  
 (a) Consider reviewing, within the framework of national legal systems, 
domestic legislation and regulatory and administrative mechanisms, as well as 
procedures including domestic distribution channels, with the aim of simplifying 
and streamlining those processes and removing unduly restrictive regulations and 
impediments, where they exist, to ensure access to controlled substances for medical 
and scientific purposes, including for the relief of pain and suffering, as required by 
the three international drug control conventions and defined by national legislation, 
while preventing their diversion, abuse and trafficking, and encourage the exchange 
of information, lessons learned and best practices in designing and implementing 
regulatory, financial, educational, administrative and other related measures;   
 (b) Strengthen, as appropriate, the proper functioning of national control 
systems and domestic assessment mechanisms and programmes, in cooperation with 
the International Narcotics Control Board, the United Nations Office on Drugs and 
Crime, the World Health Organization and other relevant United Nations system 
agencies, to identify, analyse and remove impediments to the availability and 
accessibility of controlled substances for medical and scientific purposes, within 
appropriate control mechanisms, as required by the three international drug control 
conventions and taking into account Ensuring Balance in National Policies on 
Controlled Substances: Guidance for Availability and Accessibility of Controlled 
Medicines9 and, for that purpose, consider the provision of technical and financial 
assistance, upon request, to developing countries;  
 (c) Expedite, in accordance with national legislation, the process of issuing 
import and export authorizations for controlled substances for medical and scientific 
__________________ 
 
9  World Health Organization (Geneva, 2011).   
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purposes by using the above-mentioned guidance and the International Import and 
Export Authorization System of the International Narcotics Control Board;  
 (d) Address, at the national and international levels, issues related to the 
affordability of controlled substances for medical and scientific purposes, while 
ensuring their quality, safety and efficacy, including limited financial resource s and 
problems in sourcing with regard to these substances, including in cooperation, as 
appropriate, with the private sector through, inter alia and where needed, expanding 
the national coverage of distribution networks to rural areas, addressing the link  
with government regulations, licences and taxation and allowing appropriately 
trained and qualified professionals to prescribe, dispense and administer controlled 
medicines based on their general professional licence, as well as, where appropriate, 
the manufacture of generic pharmaceutical preparations that are bioequivalent and 
cost-effective;  
 (e) Take measures, in accordance with national legislation, to provide 
capacity-building and training, including with the support of relevant United 
Nations entities such as the World Health Organization and the United Nations 
Office on Drugs and Crime, targeted at competent national authorities and health -
care professionals, including pharmacists, on adequate access to and use of 
controlled substances for medical and scientific purposes, including the relief of 
pain and suffering, consider the development and wider implementation of relevant 
clinical guidelines on the rational use of controlled medicines, and conduct 
appropriate awareness-raising campaigns under the coordination of relevant national 
health authorities and in cooperation with other relevant stakeholders;   
 (f) Develop national supply management systems for controlled substances 
that comprise selection, quantification, procurement, storage, distribution and use, 
strengthen the capacity of competent national authorities to adequately estimate and 
assess the need for controlled substances and paying special attention to essential 
medicines, as defined by national legislation, taking due note of the Guide on 
Estimating Requirements for Substances under International Control ,10 and enhance 
domestic data-collection mechanisms in order to present the International Narcotics 
Control Board with estimates on the consumption of drugs used for medical and 
scientific purposes;  
 (g) Continue to regularly update the Model Lists of Essential Medicines of 
the World Health Organization, enhance collaboration among Member States and 
the treaty bodies with scheduling responsibilities, leading to informed and 
coordinated scheduling decisions by the Commission on Narcotic Drugs that take 
due account of all relevant aspects to ensure that the objectives of the conventions 
are met, and review national lists of controlled substances and national lists of 
essential medicines, as appropriate.  
 
 
__________________ 
 
10  International Narcotics Control Board and World Health Organization (Vienna, 2012).   
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  Operational recommendations on supply reduction and related 
measures; effective law enforcement; responses to drug-related 
crime; and countering money-laundering and promoting 
judicial cooperation  
 
 
3. We reiterate our commitment to protecting the safety and assuring the security 
of individuals, societies and communities by intensifying our efforts to prevent and 
counter the illicit cultivation, production and manufacture of and trafficking in 
narcotic drugs and psychotropic substances, as well as drug -related crime and 
violence, through, inter alia, more effective drug -related crime prevention and law 
enforcement measures, as well as by addressing links with other forms of organized 
crime, including money-laundering, corruption and other criminal activities, 
mindful of their social and economic causes and consequences, and we recommend 
the following measures:  
 
  Prevention of drug-related crime  
 
 (a) Strengthen multidisciplinary measures at the international, regional, 
national, and local and community levels to prevent drug -related crime, violence, 
victimization and corruption and foster social development and inclusiveness, 
integrate such measures into overall law enforcement efforts and comprehensive 
policies and programmes, and promote a culture of lawfulness, as described in the 
Doha Declaration on Integrating Crime Prevention and Criminal Justice into the 
Wider United Nations Agenda to Address Social and Economic Challenges and to 
Promote the Rule of Law at the National and International Levels, and Public 
Participation;  
 (b) Promote comprehensive supply reduction efforts that include preventive 
measures addressing, inter alia, the criminal justice and socioeconomic -related 
factors that may facilitate, drive, enable and perpetuate organized crime and drug -
related crime;  
 (c) Promote data collection, research and the sharing of information, as well 
as the exchange of best practices on preventing and countering drug -related crime 
and on drug supply reduction measures and practices, in order to enhance the 
effectiveness of criminal justice responses, within the framework of applicable law;   
 
  Countering illicit traffic in narcotic drugs and psychotropic substances  
 
 (d) Increase cooperation at all levels and enhance measures to prevent and 
significantly and measurably reduce or eliminate the illicit cultivation of opium 
poppy, coca bush and cannabis plant used for the production of narcotic drugs and 
psychotropic substances, including through eradication, within the framework of 
sustainable crop control strategies and measures;  
 (e) Monitor current trends and drug trafficking routes and share experiences, 
best practices and lessons learned, in order to prevent and counter the misuse of 
international trade for illicit drug-related activities, and note the success achieved 
through United Nations Office on Drugs and Crime operational initiatives , including 
initiatives aimed at countering the exploitation of freight containers for drug 
trafficking and at preventing and countering the diversion of precursors for illicit 
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use and illicit financial flows stemming from drug trafficking and related crimes, as 
well as other technical assistance activities;  
 (f) Promote and strengthen the exchange of information and, as appropriate, 
drug-related criminal intelligence among law enforcement and border control 
agencies, including through the United Nations Office on Drugs and Crime 
multilateral portals and regional information centres and networks, and promote 
joint investigations and coordinate operations, in conformity with national 
legislation, and training programmes at all levels, in order to identify, d isrupt and 
dismantle organized criminal groups operating transnationally that are involved in 
any activities related to the illicit production of and trafficking in narcotic drugs and 
psychotropic substances and the diversion of their precursors and related money-
laundering;  
 (g) Strengthen coordinated border management strategies, as well as the 
capacity of border control and law enforcement and prosecutorial agencies, including  
through technical assistance, upon request, including and where appropriate, the 
provision of equipment and technology, along with necessary training and 
maintenance support, in order to prevent, monitor and counter trafficking in drugs, 
trafficking in precursors and other drug-related crimes such as trafficking in 
firearms, illicit financial flows, smuggling of bulk cash and money -laundering;  
 (h) Enhance the capacity of law enforcement and criminal justice agencies in 
forensic science in the context of drug investigations, including the quality and 
capacity of drug analysis laboratories to gather, preserve and present forensic 
evidence to effectively prosecute drug-related offences through considering, inter 
alia, the provision of advanced detection equipment, scanners, testing kits, reference 
samples, forensic laboratories and training, as requested;  
 (i) Strengthen regional, subregional and international cooperation in 
criminal matters, as appropriate, including judicial cooperation in the areas of, inter 
alia, extradition, mutual legal assistance and transfer of proceedings, in  accordance 
with the international drug control conventions and other international legal 
instruments and national legislation, and strive to provide appropriate resources to 
national competent authorities, including through the provision of targeted techn ical 
assistance to requesting countries;  
 (j) Maximize the effectiveness of law enforcement measures against 
organized criminal groups and individuals involved in drug -related crimes, 
including by placing appropriate focus within our respective jurisdictions on those 
responsible for illicit activities of a larger scale or more serious nature;   
 
  Addressing links with other forms of organized crime, including 
money-laundering, corruption and other criminal activities  
 
 (k) Respond to the serious challenges posed by the increasing links between 
drug trafficking, corruption and other forms of organized crime, including 
trafficking in persons, trafficking in firearms, cybercrime and money -laundering, 
and, in some cases, terrorism, including money-laundering in connection with the 
financing of terrorism, by using an integrated, multidisciplinary approach, such as 
through promoting and supporting reliable data collection, research and, as 
appropriate, intelligence- and analysis-sharing to ensure effective policymaking and 
interventions;  
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 (l) Encourage the use of existing subregional, regional and international 
cooperation mechanisms to combat all forms of drug-related crime, wherever 
committed, including, in some cases, violent crimes related to gangs,  including by 
enhancing international cooperation to successfully counter and dismantle organized 
criminal groups, including those operating transnationally;   
 (m) Strengthen national, regional and international measures and, as 
appropriate, rules and regulations aimed at enhancing operational cooperation to 
prevent transnational organized criminal networks involved in illicit drug -related 
activities from trafficking and acquiring firearms, their parts and components and 
ammunition, explosives and other related material;  
 (n) Consider ratifying or acceding to relevant international legal instruments, 
including the United Nations Convention against Transnational Organized Crime 
and the Protocols thereto,11 the United Nations Convention against Corruption12 
and the international conventions and protocols related to countering terrorism, and 
call upon States parties to take measures to more effectively implement those 
international legal instruments;  
 (o) Continue to foster international cooperation by implement ing the 
provisions against money-laundering contained in all relevant international and 
multilateral instruments, such as the 1988 Convention, the Organized Crime 
Convention and the Convention against Corruption and, in accordance with national 
legislation, the Financial Action Task Force Recommendations on Money 
Laundering;13  
 (p) Strengthen and utilize existing and relevant regional, as appropriate, 
subregional and international networks for the exchange of operational information 
to prevent and counter money-laundering, illicit financial flows and terrorist 
financing;  
 (q) Develop and strengthen, as appropriate, mechanisms of domestic 
coordination and timely and efficient information-sharing between authorities 
involved in identifying and countering drug trafficking, diversion of precursors and 
related money-laundering, integrate financial investigations more thoroughly into 
interdiction operations to identify individuals and companies involved in such 
activities, and encourage, in accordance with national legislation, cooperation with 
the private sector, including financial institutions, designated non -financial 
businesses and professions, as well as providers of money or value transfer services, 
to identify suspicious transactions, with a view to further  investigating and 
disrupting the drug trafficking business model;  
 (r) Enhance national, regional, subregional, interregional and international 
capacity to prevent and counter money-laundering and illicit financial flows 
stemming from drug trafficking and related crimes, including, as appropriate, 
through detection, investigation and prosecution of such activities, with a view to 
effectively addressing safe havens, and identify and mitigate money -laundering 
risks linked to new technologies, as well as emerging money-laundering methods 
__________________ 
 
11  United Nations, Treaty Series, vols. 2225, 2237, 2241 and 2326, No. 39574.  
 
12  Ibid., vol. 2349, No. 42146.  
 
13  Financial Action Task Force, International Standards on Combating Money Laundering and the 
Financing of Terrorism and Proliferation  (Paris, 2015).  
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and techniques, by using, inter alia, existing United Nations Office on Drugs and 
Crime technical assistance tools;  
 (s) Develop and strengthen bilateral, subregional and international 
mechanisms to share information among competent authorities and promote their 
cooperation to effectively and in a timely manner identify, trace, freeze, seize and 
confiscate assets and proceeds of drug-related crime and their disposal, including 
sharing, in accordance with the 1988 Convention, as well as their return, in 
appropriate drug-related corruption cases, in the framework of the Convention 
against Corruption, or, as appropriate, in cases of drug -related crimes involving 
transnational organized groups, consistent with the Organized Crime  Convention; 
and encourage the timely sharing of operational information among relevant law 
enforcement and prosecutorial agencies and financial intelligence units;   
 (t) Promote effective measures capable of addressing the links between 
drug-related crimes and corruption, as well as obstruction of justice, including 
through the intimidation of justice officials, as a part of national anti -corruption and 
drug control strategies;  
 (u) Improve the availability and quality of statistical information and 
analysis of illicit drug cultivation, production and manufacturing, drug trafficking, 
money-laundering and illicit financial flows, including for appropriate reflection in 
reports of the United Nations Office on Drugs and Crime and the International 
Narcotics Control Board, in order to better measure and evaluate the impact of such 
crimes and to further enhance the effectiveness of criminal justice responses in that 
regard.  
  Operational recommendations on cross-cutting issues: drugs and 
human rights, youth, children, women and communities  
 
 
4. We reiterate our commitment to respecting, protecting and promoting all 
human rights, fundamental freedoms and the inherent dignity of all individuals and 
the rule of law in the development and implementation of drug pol icies, and we 
recommend the following measures:  
 
  Drugs and human rights, youth, women, children, vulnerable members of society, 
and communities  
 
 (a) Enhance the knowledge of policy-makers and the capacity, as 
appropriate, of relevant national authorities on various aspects of the world drug 
problem in order to ensure that national drug policies, as part of a comprehensive, 
integrated and balanced approach, fully respect all human rights and fundamental 
freedoms and protect the health, safety and well-being of individuals, families, 
vulnerable members of society, communities and society as a whole, and to that end 
encourage cooperation with and among the United Nations Office on Drugs and 
Crime, the International Narcotics Control Board, the World Health Organization 
and other relevant United Nations entities, within their respective mandates, 
including those relevant to the above-mentioned issues, and relevant regional and 
international organizations, as well as with civil society and the private  sector, as 
appropriate;  
 (b) Ensure non-discriminatory access to health, care and social services in 
prevention, primary care and treatment programmes, including those offered to 
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persons in prison or pretrial detention, which are to be on a level equal t o those 
available in the community, and ensure that women, including detained women, 
have access to adequate health services and counselling, including those particularly 
needed during pregnancy;  
 (c) Promote effective supervision of drug treatment and rehabilitation 
facilities by competent domestic authorities to ensure adequate quality of drug 
treatment and rehabilitation services and to prevent any possible acts of cruel, 
inhuman or degrading treatment or punishment, in accordance with domestic 
legislation and applicable international law;  
 (d) Continue to identify and address protective and risk factors, as well as 
the conditions that continue to make women and girls vulnerable to exploitation and 
participation in drug trafficking, including as couriers, with a view to preventing 
their involvement in drug-related crime;  
 (e) Promote, in accordance with domestic legislation, effective coordination 
among the justice, education and law enforcement sectors and social services to 
ensure that the specific needs, including mental and physical needs, of underage 
drug offenders and children affected by drug-related crime are appropriately 
considered, including in criminal justice proceedings where required, including by 
providing those in need with drug treatment and related support services;  
 (f) Implement age-appropriate practical measures, tailored to the specific 
needs of children, youth and other vulnerable members of society, in the legislative, 
administrative, social, economic, cultural and educational sectors, including 
measures to provide them with opportunities for healthy and self -sustained lives, in 
order to prevent their abuse of narcotic drugs and psychotropic substances, and 
address their involvement, use and exploitation in the illicit cultivation  of crops, 
production, manufacturing and trafficking of narcotic drugs, psychotropic 
substances and other forms of drug-related crime, including urban crime, youth and 
gang-related violence and crime, fulfilling the obligations as States parties to the 
Convention on the Rights of the Child and taking into account the United Nations 
Guidelines for the Prevention of Juvenile Delinquency (the Riyadh Guidelines); 14  
 (g) Mainstream a gender perspective into and ensure the involvement of 
women in all stages of the development, implementation, monitoring and evaluation 
of drug policies and programmes, develop and disseminate gender -sensitive and 
age-appropriate measures that take into account the specific needs and 
circumstances faced by women and girls with regard to the world drug problem and, 
as States parties, implement the Convention on the Elimination of All Forms of 
Discrimination against Women;15  
 (h) Consider, on a voluntary basis, when furnishing information to the 
Commission on Narcotic Drugs pursuant to the three international drug control 
conventions and relevant Commission resolutions, the inclusion of information 
concerning, inter alia, the promotion of human rights and the health, safety and 
welfare of all individuals, communities and society in the context of their domestic 
implementation of these conventions, including recent developments, best practices 
and challenges;  
__________________ 
 
14  Resolution 45/112, annex.  
 
15  United Nations, Treaty Series, vol. 1249, No. 20378.  
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 (i) Ensure that measures to prevent the illicit cultivation of and to eradicate 
plants containing narcotic and psychotropic substances respect fundamental human 
rights, take due account of traditional licit uses, where there is historic evidence of 
such use, and of the protection of the environment, in accordance with the three 
international drug control conventions, and also take into account, as appropriate 
and in accordance with national legislation, the United Nations Declaration on the 
Rights of Indigenous Peoples;16  
 
  Proportionate and effective policies and responses, as well as legal guarantees 
and safeguards pertaining to criminal justice proceedings and the justice sector  
 
 (j) Encourage the development, adoption and implementation, with due 
regard to national, constitutional, legal and administrative systems, of alternative or 
additional measures with regard to conviction or punishment in cases of an 
appropriate nature, in accordance with the three international drug control 
conventions and taking into account, as appropriate, relevant United Nations 
standards and rules, such as the United Nations Standard Minimum Rules for 
Non-Custodial Measures (the Tokyo Rules);  
 (k) Consider sharing, through the Commission on Narcotic Drugs, 
information, lessons learned, experiences and best practices on the design, 
implementation and results of national criminal justice policies, including, as 
appropriate, domestic practices on proportional sentencing, related to the 
implementation of the three international drug control conventions, including article 3  
of the 1988 Convention;  
 (l) Promote proportionate national sentencing policies, practices and 
guidelines for drug-related offences whereby the severity of penalties is 
proportionate to the gravity of offences and whereby both mitigating and 
aggravating factors are taken into account, including the circumstances enumerated 
in article 3 of the 1988 Convention and other relevant and applicable international 
law, and in accordance with national legislation;  
 (m) Enhance access to treatment of drug use disorders for those incarcerated 
and promote effective oversight and encourage, as appropriate, self -assessments of 
confinement facilities, taking into consideration the United Nations standards and 
norms on crime prevention and criminal justice, including the United Nations 
Standard Minimum Rules for the Treatment of Prisoners (the Nelson Mandela 
Rules),17 implement, where appropriate, measures aimed at addressing and 
eliminating prison overcrowding and violence, and provide capacity -building to 
relevant national authorities;  
 (n) Encourage the taking into account of the specific needs and possible 
multiple vulnerabilities of women drug offenders when imprisoned, in line with the 
United Nations Rules for the Treatment of Women Prisoners and Non -custodial 
Measures for Women Offenders (the Bangkok Rules);18  
 (o) Promote and implement effective criminal justice responses to drug -
related crimes to bring perpetrators to justice that ensure legal guarantees and due 
process safeguards pertaining to criminal justice proceedings, including practical 
__________________ 
 
16  Resolution 61/295, annex.  
 
17  Resolution 70/175, annex.  
 
18  Resolution 65/229, annex.  
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measures to uphold the prohibition of arbitrary arrest and detention and of torture 
and other cruel, inhuman or degrading treatment or punishment and to eliminate 
impunity, in accordance with relevant and applicable international law and taking 
into account United Nations standards and norms on crime prevention and criminal 
justice, and ensure timely access to legal aid and the right to a fair trial.  
  Operational recommendations on cross-cutting issues in 
addressing and countering the world drug problem: evolving 
reality, trends and existing circumstances, emerging and persistent 
challenges and threats, including new psychoactive substances, in 
conformity with the three international drug control conventions 
and other relevant international instruments  
 
 
5. We reiterate our commitment to strengthen our efforts in addressing and 
countering emerging and persistent challenges and threats of all aspects of the world 
drug problem, and note the need to effectively respond to the evolving reality, 
trends and existing circumstances through comprehensive, integrated and balanced 
drug control policies and programmes that take into account their transnational 
implications and that are in conformity with the three international drug control 
conventions and other relevant international instruments, and to strengthen our 
international, regional and subregional cooperation, and we recommend the following:  
 
  Addressing new psychoactive substances, amphetamine-type stimulants, 
including methamphetamine, the diversion of precursors and pre-precursors and 
the non-medical use and misuse of pharmaceuticals containing narcotic drugs 
and psychotropic substances  
 
 We resolve to strengthen national and international action to address the 
emerging challenge of new psychoactive substances, including their adverse health 
consequences, and the evolving threat of amphetamine-type stimulants, including 
methamphetamine, and underscore the importance of enhancing information -sharing 
and early warning networks, developing appropriate national legislative, prevention 
and treatment models and supporting scientific evidence -based review and 
scheduling of the most prevalent, persistent and harmful substances, we note the 
importance of preventing the diversion and misuse of pharmaceuticals containing 
narcotic drugs and psychotropic substances and precursors while ensuring their 
availability for legitimate purposes, and we recommend the following measures:  
 (a) Encourage the development and implementation of, as appropriate and in 
accordance with national legislation, comprehensive measures and programmes, as 
outlined in paragraph 1 of this document, adapt those measures to the risks and 
challenges posed by the use of new psychoactive substances and amphetamine -type 
stimulants, including methamphetamine, and the non -medical use and misuse of 
pharmaceuticals containing narcotic drugs and psychotropic substances, and 
actively share information on best practices and lessons learned with regard to 
national health-related experiences;  
 (b) Enhance the capacity of law enforcement agencies to detect and identify 
new psychoactive substances and amphetamine-type stimulants, including 
methamphetamine, and promote cross-border cooperation and information-sharing 
to prevent their abuse and diversion, including through the use of existing 
 
A/S-30/L.1 
 
17/24 16-06128 
 
International Narcotics Control Board and United Nations Office on Drugs and 
Crime tools and projects;  
 (c) Establish and strengthen partnerships and information exchange with 
industries, in particular with chemical and pharmaceutical industries and other 
relevant private sector entities, and encourage the use of the Guidelines for a 
Voluntary Code of Practice for the Chemical Industry , issued by the International 
Narcotics Control Board, and the Board’s model memorandum of understanding 
between governments and private sector partners, as and where appropriate, bearing 
in mind the important role these industries can play in addressing and countering the 
world drug problem;  
 
  New psychoactive substances  
 
 (d) Continue to identify and monitor trends in the composition, production, 
prevalence and distribution of new psychoactive substances, as well as patterns of 
use and adverse consequences, and assess the risks to health and safety of 
individuals and society as a whole and the potential uses of new psychoactive 
substances for medical and scientific purposes, and on that basis to  develop and 
strengthen domestic and national legislative, regulatory, administrative and 
operational responses and practices by domestic and national legislative, law 
enforcement, judiciary, social and welfare, educational and health authorities;   
 (e) Commit to implementing timely, scientific evidence-based control or 
regulatory measures within national legislative and administrative systems to tackle 
and manage the challenge of new psychoactive substances, and consider the use of 
interim steps while substances are under review, such as provisional measures of 
control, or make public health announcements, as well as share information and 
expertise on those measures;  
 (f) Share relevant information with, as appropriate, and strengthen the 
capacity of the World Health Organization, the United Nations Office on Drugs and 
Crime, the International Narcotics Control Board and other relevant international 
and regional organizations to prioritize the review of the most prevalent, persistent 
and harmful new psychoactive substances and to facilitate informed scheduling 
decisions by the Commission on Narcotic Drugs;  
 (g) Actively participate in early warning networks and promote the use of 
relevant surveillance lists and voluntary controls and the sharing of informat ion 
through the International Narcotics Control Board, the United Nations Office on 
Drugs and Crime and the World Health Organization, within their respective 
mandates, and enhance bilateral, subregional, regional and international cooperation 
in the identification and reporting of new psychoactive substances and incidents 
involving such substances and, to that end, strengthen the use of national, regional 
and international established reporting and information exchange systems, such as, 
where appropriate, the early warning advisory on new psychoactive substances and 
the global Synthetics Monitoring: Analysis, Reporting and Trends (SMART) 
programme of the United Nations Office on Drugs and Crime and Project Ion of the 
International Narcotics Control Board;  
 (h) Enhance the capacity and effectiveness of national laboratories and 
promote national and regional cooperation among them, as appropriate, for the 
detection and identification of new psychoactive substances, including through the 
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use of existing United Nations Office on Drugs and Crime reference standards and 
assistance activities; 
 (i) Strengthen domestic information-sharing and promote information 
exchange at the regional and international levels on effective prevention and 
treatment and related legislative measures in order to support the development of 
effective, scientific evidence-based responses to the emerging challenge of new 
psychoactive substances with regard to their adverse social and health consequences;   
 
  Amphetamine-type stimulants, including methamphetamine  
 
 (j) Support existing research, collection and scientific analysis of data 
related to amphetamine-type stimulants through the global SMART programme and 
relevant International Narcotics Control Board tools, such as Project Prism, a nd 
strengthen cooperation at all levels in tackling amphetamine -type stimulants, 
including methamphetamine;  
 (k) Promote the use, as appropriate, of relevant existing programmes, 
mechanisms and coordinated operations at all levels and continue the develop ment 
and sharing of best practices and lessons learned among practitioners with regard to 
a balanced and integrated approach to the evolving threat of amphetamine -type 
stimulants;  
 
  Precursors and pre-precursors  
 
 (l) Strengthen national, regional and international monitoring of chemicals 
used in the illicit manufacture of drugs and new psychoactive substances, with a 
view to more effectively preventing the diversion of and trafficking in those 
chemicals, while ensuring that the legitimate trade in and use of those chemicals are 
not adversely affected, including by using national, subregional and international 
reporting systems and International Narcotics Control Board tools such as Project 
Prism, the Precursors Incident Communication System and Pre -Export Notification 
Online (PEN Online);  
 (m) Take appropriate measures to address the diversion and illicit 
manufacturing of and trafficking in as well as misuse of precursors under 
international control and to tackle the misuse of pre-precursors and substitute or 
alternative precursors for illicit drug manufacturing, and enhance voluntary efforts, 
including voluntary codes of conduct in cooperation with relevant industries and 
commerce at the national, regional and international levels, including through use  of 
relevant International Narcotics Control Board tools;  
 
  Non-medical use and misuse of pharmaceuticals  
 
 (n) Enhance the sharing of information on the misuse of pharmaceuticals 
containing narcotic drugs and psychotropic substances, and the quality and 
consistency of reported data, including through the annual report questionnaire of 
the United Nations Office on Drugs and Crime;  
 (o) Develop and implement countermeasures and supportive public health, 
education and socioeconomic strategies to effectively address and counter the 
non-medical use and misuse of pharmaceuticals that contain narcotic drugs and 
psychotropic substances, while ensuring their availability for legitimate purposes, 
and promote national subregional, regional and international cooperation to prevent 
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their diversion, trafficking and abuse, including through the use of existing World 
Health Organization, United Nations Office on Drugs and Crime and International 
Narcotics Control Board projects and tools;  
 
  Use of the Internet in relation to drug-related activities  
 
 (p) Support research, data collection, analysis of evidence and sharing of 
information and strengthen law enforcement, criminal justice and legal responses, as 
well as international cooperation, to prevent and counter drug-related criminal 
activities using the Internet, consistent with relevant and applicable law;   
 (q) Increase the provision of technical assistance and capacity-building at all 
levels to Member States, upon request, to prevent and counter the use of 
technologies, including the Internet, by drug trafficking networks and transnational 
criminal organizations, to facilitate drug-related activities;  
 (r) Enhance the capacity of national authorities, in particular law 
enforcement authorities, to preserve and analyse electronic evidence related to illicit 
activities, including drug trafficking and money-laundering, and to monitor sales of 
illicit drugs using the Internet;  
 (s) Encourage the use of the Guidelines for Governments on Preventing the 
Illegal Sale of Internationally Controlled Substances through the Internet ,19 as 
appropriate;  
 (t) Support measures on the use of the Internet for prevention purposes, 
including appropriate counselling and information provision, develop, implement 
and promote, in accordance with national legislation, prevention strategies, 
programmes and measures, including via social media and other social networks, 
aimed at, inter alia, protecting children and young people from the abuse of 
controlled substances and new psychoactive substances and from involvement in 
their illicit sale and purchase via the Internet, and enhance cooperation at all levels 
in that regard;  
 
  Evolving reality, trends and existing circumstances, emerging and persistent 
challenges and threats  
 
 (u) Promote, as appropriate, the use and analysis of relevant, reliable and 
objective data generated by national and regional monitoring and evaluation to 
improve the implementation of comprehensive, integrated and balanced national 
drug control strategies, policies and programmes, in conformity with the three 
international drug control conventions and other relevant international instruments, 
and encourage the sharing of best practices and lessons learned, including through 
the Commission on Narcotic Drugs and other relevant regional and international 
organizations, within their mandates, to, inter alia, better understand both their 
domestic and transnational implications;  
 (v) Intensify efforts in the context of long-term and sustainable development 
programmes to address the most pressing drug-related socioeconomic factors, 
including unemployment and social marginalization, conducive to their subsequent 
exploitation by criminal organizations involved in drug -related crime;  
__________________ 
 
19  United Nations publication, Sales No. E.09.XI.6.   
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 (w) Encourage the Commission on Narcotic Drugs, in cooperation with 
relevant United Nations entities, within their respective mandates, to consider, as 
appropriate, reviewing existing guidelines and, where required, developing new 
ones on the various aspects of the world drug problem, with a view to enhancing the 
capacity of relevant national authorities and strengthening international and 
inter-agency cooperation;  
 (x) Promote exchange of information to better understand the extent of 
adverse impacts, including the health, social and economic and safety impacts, of 
drug trafficking in small quantities in order to develop, where appropriate effective 
responses to counter microtrafficking;  
 (y) Call upon the United Nations Office on Drugs and Crime, the 
International Narcotics Control Board, the World Health Organization and other 
United Nations entities with pertinent technical and operational expertise, within 
their mandates, to continue to provide, upon request, advice and assistance to States 
that are reviewing and updating their drug policies, in compliance with the 
international drug control conventions, taking into account their national priorities 
and needs through, among others, the promotion of exchange of information and 
best practices on scientific evidence-based policies adopted by States.  
 
 
  Operational recommendations on strengthening international 
cooperation based on the principle of common and 
shared responsibility  
 
 
6. We reiterate our commitment to supporting our efforts at all levels, based on 
common and shared responsibility, to effectively address and counter the world drug 
problem and to enhance international cooperation and, to that end, we recommend 
the following measures:  
 (a) Strengthen specialized, targeted, effective and sustainable technical 
assistance, including, where appropriate, adequate financial assistance, training, 
capacity-building, equipment and technological know-how, to requesting countries, 
including transit countries, through and in cooperation with the United Nations 
Office on Drugs and Crime, as well as the World Health Organization and other 
relevant United Nations entities and international and regional organizations, within 
their respective mandates, to assist Member States to effectively address the health, 
socioeconomic, human rights, justice and law enforcement aspects of the world drug 
problem;  
 (b) Enhance North-South, South-South and triangular cooperation among 
Member States, in cooperation with the international development community and 
other key stakeholders, in order to effectively address and counter the world drug 
problem;  
 (c) Strengthen, including through the Commission on Narcotic Drugs and, as 
appropriate, its subsidiary bodies, the regular exchange of information, good 
practices and lessons learned among national practitioners from different fields and 
at all levels to effectively implement an integrated and balanced approach to the 
world drug problem and its various aspects and consider additional measures to 
further facilitate meaningful discussion among those practitioners;   
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 (d) Encourage the Commission on Narcotic Drugs to contribute to the global 
follow-up and support the thematic review of progress on the Sustainable 
Development Goals,20 within its mandates, bearing in mind the integrated nature of 
the Goals as well as the interlinkages between them, and make that information 
available to the high-level political forum through the appropriate institutional 
framework, taking into account General Assembly resolution 70/1;  
 (e) Encourage the Commission on Narcotic Drugs and the United Nations 
Office on Drugs and Crime to further increase cooperation and collaboration with 
all relevant United Nations entities and international financial insti tutions, within 
their respective mandates, when assisting Member States in designing and 
implementing comprehensive, integrated and balanced national drug strategies, 
policies and programmes.  
 
 
  Operational recommendations on alternative development; 
regional, interregional and international cooperation on 
development-oriented balanced drug control policy; addressing 
socioeconomic issues 
 
 
7. We reiterate our commitment to addressing drug-related socioeconomic issues 
related to the illicit cultivation of narcotic plants and the illicit manufacture and 
production and trafficking of drugs through the implementation of long -term, 
comprehensive and sustainable development-oriented and balanced drug control 
policies and programmes, including alternative development and, as appropriate, 
preventive alternative development programmes, which are part of sustainable crop 
control strategies, and we recommend the following measures:   
 
  Socioeconomic issues and alternative development  
 
 (a) Target the illicit cultivation of crops used for the illicit production and 
manufacture of drugs and address related factors by implementing comprehensive 
strategies aimed at alleviating poverty and strengthening the rule of law, 
accountable, effective and inclusive institutions and public services and institutional 
frameworks, as appropriate, and by promoting sustainable development aimed at 
enhancing the welfare of the affected and vulnerable population through licit 
alternatives;  
 (b) Encourage the promotion of inclusive economic growth and support 
initiatives that contribute to poverty eradication and the sustainability of social and 
economic development, develop measures for rural development, improving 
infrastructure and social inclusion and protection, addressing the consequences of 
illicit crop cultivation and the manufacture and production of narcotic drugs and 
psychotropic substances on the environment, with the incorporation and 
participation of local communities, and consider taking voluntary measures to 
promote products stemming from alternative development, including preventive 
alternative development, as appropriate, to gain access to markets, consistent with 
applicable multilateral trade rules and with national and international law, within the 
framework of comprehensive and balanced drug control strategies;  
__________________ 
 
20  Contained in resolution 70/1.  
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 (c) Express concern that illicit cultivation of crops and illicit manufacture, 
distribution and trafficking remain serious challenges in addressing and countering 
the world drug problem, and recognize the need for strengthening sustainable crop 
control strategies that may include, inter alia, alternative development, eradication 
and law enforcement measures, for the purpose of preventing and reducing 
significantly and measurably the illicit cultivation of crops, and the need for 
intensifying joint efforts at national, regional and international levels in a more 
comprehensive manner, in accordance with the principle of common and shared 
responsibility, including by means of appropriate preventive tools and measures, 
enhanced and better coordinated financial and technical assistance and action -
oriented programmes, in order to tackle those challenges;   
 (d) Consider elaborating and implementing comprehensive and sustainable 
alternative development programmes, including preventive alternative development, 
as appropriate, that support sustainable crop control strategies to prevent and 
significantly, durably and measurably reduce illicit crop cultivation and other illicit 
drug-related activities, ensuring the empowerment, ownership and responsibility of 
affected local communities, including farmers and their cooperatives, by taking into 
account the vulnerabilities and specific needs of communities affected by or at risk 
of illicit cultivation, in cooperation with the United Nations Office on Drugs and 
Crime, the Food and Agriculture Organization of the United Nations, the International  
Labour Organization, the United Nations Development Programme and other relevant  
international organizations, bearing in mind national and regional development 
policies and action plans, with a view to contributing to the building of peaceful, 
inclusive and just societies, consistent with the Sustainable Development Goals and 
in compliance with relevant and applicable international and national l aw;  
 (e) Strengthen subregional, regional and international cooperation to support 
comprehensive and sustainable alternative development programmes, including, as 
appropriate, preventive alternative development, as an essential part of successful 
prevention and crop control strategies to increase the positive outcome of such 
programmes, especially in the areas affected by and at risk of illicit cultivation of 
crops used for the production of narcotic drugs and psychotropic substances, taking 
into account the United Nations Guiding Principles on Alternative Development;21  
 (f) Strengthen regional and international cooperation to support sustainable 
alternative development programmes, including, as appropriate, preventive 
alternative development, in close collaboration with all relevant stakeholders at the 
local, national and international levels, and to develop and share best practices 
towards implementing the United Nations Guiding Principles on Alternative 
Development, taking into account all the lessons learned and good practices, in 
particular by countries with extensive expertise in alternative development, and take 
note, inter alia, of the Second International Conference on Alternative Development;   
 (g) Promote research by States, including through cooperation with the 
United Nations Office on Drugs and Crime and other relevant United Nations 
entities and international and regional organizations, academic institutions and civil 
society, to better understand factors contributing to illicit crop cultiva tion, taking 
into account local and regional specificities, and to improve impact assessment of 
alternative development programmes, including preventive alternative development, 
__________________ 
 
21  Resolution 68/196, annex.  
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as appropriate, with a view to increasing the effectiveness of these programme s, 
including through the use of relevant human development indicators, criteria related 
to environmental sustainability and other measurements in line with the Sustainable 
Development Goals;  
 
  Technical and financial cooperation for comprehensive and balanced 
development-oriented drug policies and viable economic alternatives  
 
 (h) Consider strengthening a development perspective as part of 
comprehensive, integrated and balanced national drug policies and programmes so 
as to tackle the related causes and consequences of illicit cultivation, manufacture, 
production of and trafficking in drugs by, inter alia, addressing risk factors affecting 
individuals, communities and society, which may include a lack of services, 
infrastructure needs, drug-related violence, exclusion, marginalization and social 
disintegration, in order to contribute to the promotion of peaceful and inclusive 
societies;  
 (i) Urge relevant international financial institutions, United Nations entities, 
non-governmental organizations and the private sector, as appropriate, to consider 
increasing their support, including through long-term and flexible funding, for the 
implementation of comprehensive and balanced development -oriented drug control 
programmes and viable economic alternatives, in particular alternative development, 
including, as appropriate, preventive alternative development programmes, based on 
identified needs and national priorities, for areas and populations affected by or 
vulnerable to the illicit cultivation of drug crops, with a view to its prevention, 
reduction and elimination, and encourage States to the extent possible to stay 
strongly committed to financing such programmes;  
 (j) Encourage the development of viable economic alternatives, particularly 
for communities affected by or at risk of illicit cultivation of drug crops and other 
illicit drug-related activities in urban and rural areas, including through 
comprehensive alternative development programmes, and to this end consider 
development-oriented interventions, while ensuring that both men and women 
benefit equally from them, including through job opportunities, improved 
infrastructure and basic public services and, as appropriate, access and legal titles to 
land for farmers and local communities, which will also contribute to preventing, 
reducing or eliminating illicit cultivation and other drug -related activities;  
 (k) Consider the development of sustainable urban development initiatives 
for those affected by illicit drug-related activities to foster public participation in 
crime prevention, community cohesion, protection and safety and to stimulate 
innovation, entrepreneurship and employment;  
 (l) Promote partnerships and innovative cooperation initiatives with the 
private sector, civil society and international financial institutions to create 
conditions more conducive to productive investments targeted at job creation in 
areas and among communities affected by or at risk of illicit drug cultivation, 
production, manufacturing, trafficking and other illicit drug -related activities in 
order to prevent, reduce or eliminate them, and share best practices, lessons learned, 
expertise and skills in this regard.  
8. We express appreciation for the inclusive, transparent and open -ended 
preparatory process for the special session, led by the Commission on Narcotic 
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Drugs with the support, guidance and involvement of the President of the General 
Assembly, and for all contributions to this preparatory process.   
9. We resolve to take the necessary steps to implement the above -listed 
operational recommendations, in close partnership with the United Nations and 
other intergovernmental organizations and civil society, and to share with the 
Commission on Narcotic Drugs, as the policymaking body of the United Nations 
with prime responsibility for drug control matters, timely information on progress 
made in the implementation of these recommendations.   
 
 
